vTv Therapeutics Inc
VTVTBuild a strategy around VTVT
vTv Therapeutics Inc AI Insights
Informational only. Not investment advice.Snapshot
- Cash of 98.5M covers 4.7 years of burn at current -20.8M FCF TTM rate - extended runway post 77.5M equity raise[Cash and Equivalents]
- Revenue collapsed 80% over 3Y to just 17K TTM - essentially zero commercial operations, pure R&D play[Total Revenue 3Y Growth]
- R&D spend of 16.2M TTM is 54% of total opex - clinical-stage biotech with no marketed products[Research and Development]
Watch Triggers
- Cash and Equivalents: Falls below 40M (2yr runway) — Triggers dilutive financing or strategic alternatives discussion
- Research and Development: Increases >50% without revenue — Accelerated burn signals late-stage trials or desperation spend
- Total Revenue: Any material increase above 1M — Would indicate partnership deal or licensing milestone - thesis changer
Bull Case
Strong balance sheet with 98.5M cash, minimal debt (360K, 0.5% D/E), and 4.7yr runway provides time for pipeline maturation without near-term dilution
Trading at 3.7x book vs tangible equity of 70.5M - limited downside to cash value if pipeline fails
Bear Case
Zero commercial revenue (17K TTM) with -80% 3Y decline means 100% dependent on pipeline success - binary risk profile
Burning 20.8M annually with no path to profitability - eventual dilution or failure inevitable without clinical wins
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage VTVT's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Binary outcome: pipeline success or cash depletion by 2030 at current burn rate
- 4.7 year cash runway at -20.8M annual burn
- Zero revenue generation capability
- Clinical trial outcomes will determine survival
Valuation Context
Caveats
VTVT Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$138.02M | — | ||
$39.93M | — | ||
0.00 | — | ||
$0 | — | ||
$0.00 | — | ||
0% | — | ||
0% | — | ||
$0 | — | ||
0% | — | ||
Beta 5Y (Monthly) | unknown | — |
VTVT Dividend History
VTVT Stock Splits
VTVT SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
05/13/26 | 03/31/26 | 10-Q | |
03/10/26 | 12/31/25 | 10-K | |
11/06/25 | 09/30/25 | 10-Q | |
08/12/25 | 06/30/25 | 10-Q | |
05/15/25 | 03/31/25 | 10-Q | |
03/20/25 | 12/31/24 | Unknown | |
11/12/24 | 09/30/24 | 10-Q | |
08/08/24 | 06/30/24 | 10-Q | |
05/09/24 | 03/31/24 | 10-Q | |
03/13/24 | 12/31/23 | 10-K | |
03/20/25 | 12/31/23 | 10-K | |
11/09/23 | 09/30/23 | 10-Q | |
08/11/23 | 06/30/23 | 10-Q | |
05/11/23 | 03/31/23 | 10-Q | |
03/20/25 | 12/31/22 | 10-K | |
03/06/23 | 12/31/22 | 10-K | |
11/10/22 | 09/30/22 | 10-Q | |
08/15/22 | 06/30/22 | 10-Q | |
05/12/22 | 03/31/22 | 10-Q | |
03/29/22 | 12/31/21 | 10-K | |
11/09/21 | 09/30/21 | 10-Q | |
08/04/21 | 06/30/21 | 10-Q | |
05/05/21 | 03/31/21 | 10-Q | |
02/24/21 | 12/31/20 | 10-K | |
11/05/20 | 09/30/20 | 10-Q | |
08/03/20 | 06/30/20 | 10-Q | |
05/07/20 | 03/31/20 | 10-Q | |
02/21/20 | 12/31/19 | 10-K | |
10/30/19 | 09/30/19 | 10-Q | |
07/31/19 | 06/30/19 | 10-Q | |
05/01/19 | 03/31/19 | 10-Q | |
02/26/19 | 12/31/18 | 10-K | |
11/08/18 | 09/30/18 | 10-Q | |
08/03/18 | 06/30/18 | 10-Q | |
05/15/18 | 03/31/18 | 10-Q | |
02/27/18 | 12/31/17 | 10-K | |
11/01/17 | 09/30/17 | 10-Q | |
08/02/17 | 06/30/17 | 10-Q | |
05/03/17 | 03/31/17 | 10-Q | |
02/24/17 | 12/31/16 | 10-K | |
11/03/16 | 09/30/16 | 10-Q | |
08/02/16 | 06/30/16 | 10-Q | |
05/13/16 | 03/31/16 | 10-Q | |
03/04/16 | 12/31/15 | 10-K | |
11/13/15 | 09/30/15 | 10-Q | |
09/14/15 | 06/30/15 | 10-Q | |
07/31/15 | 03/31/15 | 424B4 | |
07/31/15 | 12/31/14 | 424B4 | |
11/13/15 | 09/30/14 | 10-Q | |
09/14/15 | 06/30/14 | 10-Q | |
07/31/15 | 03/31/14 | 424B4 |